Detalhe da pesquisa
1.
Efficacy of rituximab in anti-myelin-associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow-up.
Eur J Neurol
; 29(12): 3611-3622, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36083713
2.
Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma.
Hematol Oncol
; 39(3): 293-303, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33742718
3.
Chimeric Antigen Receptor-T Cell Therapy for Lymphoma: New Settings and Future Directions.
Cancers (Basel)
; 16(1)2023 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38201473
4.
Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Stem Cell Transplantation: Biology and Treatment Options.
J Clin Med
; 11(24)2022 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36556158
5.
HBV Reactivation in Patients with Past Infection Affected by Non-Hodgkin Lymphoma and Treated with Anti-CD20 Antibody Based Immuno-Chemotherapy: A Multicenter Experience.
J Pers Med
; 12(2)2022 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35207774
6.
Real Life Use of Bendamustine in Elderly Patients with Lymphoid Neoplasia.
J Pers Med
; 11(4)2021 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33808164
7.
COVID-19 in a Post-transplant Heart Recipient Who Developed Aggressive Lymphoma: A Biphasic Course During Rituximab Treatment.
Hemasphere
; 5(7): e592, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34131632